The Growing Use of GLP-1 Drugs Creates Opportunities for Coffee and Tea
The US FDA approved the first GLP-1 pill in December 2025. Image credit: Albaloshi-stock.adobe.com
The rise in GLP-1 use has disrupted the food and beverage space, resulting in lower appetites and more intentional food and beverage choices. For coffee and tea brands to retain GLP-1 users, they must offer products that meet these consumers’ needs and ensure that consumers clearly understand the benefits of their products so they can become an integral part of the GLP-1 user lifestyle.
By Anne-Marie Hardie.
This feature article is restricted to logged-in paid subscribers.
Login or subscribe now to view this exclusive content.
